Status:
UNKNOWN
SMART Identification of Ventricular Tachycardia Isthmus
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Ventricular Tachycardia
Ischemic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
Context : Ventricular tachycardia (VT) are serious heart rhythm disorders which can lead to sudden death. A curative treatment for these abnormalities in the cardiac electrical conduction system is p...
Eligibility Criteria
Inclusion
- Ventricular tachycardia ablation between October 2014 and April 2021
- Patient for whom electroanatomical data are available.
- Ischemic cardiomyopathy / previous myocardial infarction
- At least 30 points of pace-mapping during the VT procedure
Exclusion
- Incomplete data
- Poor quality ECG recordings
- Absence of ventricular tachycardia isthmus identified during the procedure
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04852497
Start Date
April 1 2018
End Date
September 1 2024
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Nancy
Vandœuvre-lès-Nancy, France, 54500